<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.otf"); }
.f1 { font-family:ff0,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff8; src: url("8.otf"); }
.f2 { font-family:ff8,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.otf"); }
.f3 { font-family:ff4,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff2; src: url("2.otf"); }
.f4 { font-family:ff2,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff5; src: url("5.otf"); }
.f5 { font-family:ff5,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img style="position:absolute; left:0px; top:0px;" width="595" height="793" src="page8.png"">
<div class="txt" style="position:absolute; left:37px; top:48px;"><span class="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">H. Nadeeshani, J. Li, T. Ying et al.</span></div>
<div class="txt" style="position:absolute; left:413px; top:48px;"><span class="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Journal of Advanced Research 37 (2022) 267–278</span></div>
<div class="txt" style="position:absolute; left:37px; top:67px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">process, many researches on longevity are being conducted to</span></div>
<div class="txt" style="position:absolute; left:37px; top:78px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">understand and manage the aging process through anti-aging</span></div>
<div class="txt" style="position:absolute; left:37px; top:88px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">interventions, while complying with gerontological and biogeron-</span></div>
<div class="txt" style="position:absolute; left:37px; top:99px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">tological aspects.</span></div>
<div class="txt" style="position:absolute; left:49px; top:109px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Fu and Zhang [44] have applied for a patent application for</span></div>
<div class="txt" style="position:absolute; left:37px; top:120px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">using </span><span class="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">b</span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">-NMN in the preparation of healthcare products or anti-</span></div>
<div class="txt" style="position:absolute; left:37px; top:130px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">aging drugs as a single dose of 1–500 mg/kg body weight/day of</span></div>
<div class="txt" style="position:absolute; left:37px; top:141px;"><span class="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">b</span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">-NMN. The healthcare products or anti-aging drugs was in the</span></div>
<div class="txt" style="position:absolute; left:37px; top:151px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">forms of injections, enteric-coated preparations, aqueous solutions,</span></div>
<div class="txt" style="position:absolute; left:37px; top:162px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">granules, capsules or tablets. A number of NMN anti-aging health</span></div>
<div class="txt" style="position:absolute; left:37px; top:172px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">products have been produced and launched by various pharmaceu-</span></div>
<div class="txt" style="position:absolute; left:37px; top:182px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">tical, nutraceutical, biotechnology and health food companies. The</span></div>
<div class="txt" style="position:absolute; left:37px; top:193px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">quantity of NMN in available commercial products vary from 50 to</span></div>
<div class="txt" style="position:absolute; left:37px; top:203px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">150 mg/capsule, whereas some consumers take two 150 mg cap-</span></div>
<div class="txt" style="position:absolute; left:37px; top:214px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">sules per day [57]. Nowadays, there are NMN products, marketed</span></div>
<div class="txt" style="position:absolute; left:37px; top:224px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">as supplements for anti-aging and longevity in the form of cap-</span></div>
<div class="txt" style="position:absolute; left:37px; top:235px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">sules, which are very high in dose such as </span><span class="f3" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">!</span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">500 mg. The safety</span></div>
<div class="txt" style="position:absolute; left:37px; top:245px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">of these doses cannot be assessed since required clinical and toxi-</span></div>
<div class="txt" style="position:absolute; left:37px; top:256px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">cological studies have not been completed yet to establish the rec-</span></div>
<div class="txt" style="position:absolute; left:37px; top:266px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ommended safe levels for long term administration. Nevertheless,</span></div>
<div class="txt" style="position:absolute; left:37px; top:277px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">their safety and efﬁcacy are uncertain and unreliable since most of</span></div>
<div class="txt" style="position:absolute; left:37px; top:287px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">them have not been backed up by rigorous scientiﬁc preclinical</span></div>
<div class="txt" style="position:absolute; left:37px; top:298px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and clinical testing. This issue has been arisen as manufacturers</span></div>
<div class="txt" style="position:absolute; left:37px; top:308px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">are hesitant to pay for research and clinical trials due to potential</span></div>
<div class="txt" style="position:absolute; left:37px; top:318px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">lower proﬁt margin, and there is no authorising agency to regulate</span></div>
<div class="txt" style="position:absolute; left:37px; top:329px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN products because it is often sold as functional food product</span></div>
<div class="txt" style="position:absolute; left:37px; top:339px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">rather than heavily regulated therapeutic drug. Therefore, more</span></div>
<div class="txt" style="position:absolute; left:37px; top:350px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">strict approval process has been demanded by consumer advocacy</span></div>
<div class="txt" style="position:absolute; left:37px; top:360px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">groups requesting regulatory agencies to set standard and restric-</span></div>
<div class="txt" style="position:absolute; left:37px; top:371px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">tions for marketing anti-aging health products, considering safety,</span></div>
<div class="txt" style="position:absolute; left:37px; top:381px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">health and wellbeing of consumers [58]. NMN should not be con-</span></div>
<div class="txt" style="position:absolute; left:37px; top:392px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">sidered as a panacea for the elderly, because boosting NAD levels</span></div>
<div class="txt" style="position:absolute; left:37px; top:402px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">when not required may yield some detrimental effects. Therefore,</span></div>
<div class="txt" style="position:absolute; left:37px; top:413px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">the dose and frequency of NMN supplementation should be care-</span></div>
<div class="txt" style="position:absolute; left:37px; top:423px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">fully prescribed depending on the type of age-related deﬁciency</span></div>
<div class="txt" style="position:absolute; left:37px; top:434px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and all other confronting health conditions of the people [59].</span></div>
<div class="txt" style="position:absolute; left:37px; top:444px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Other NAD precursors have been studied to discover the efﬁcacy</span></div>
<div class="txt" style="position:absolute; left:37px; top:454px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">for diverse age-related deﬁciencies and they are used for particular</span></div>
<div class="txt" style="position:absolute; left:37px; top:465px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">deﬁciencies, only after they are proven for effectiveness and safe to</span></div>
<div class="txt" style="position:absolute; left:37px; top:475px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">use. Therefore, the same principle should be applied to NMN as</span></div>
<div class="txt" style="position:absolute; left:37px; top:486px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">well [60,61].</span></div>
<div class="txt" style="position:absolute; left:49px; top:496px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Grozio et al. [62] reported that NMN was speedily absorbed in</span></div>
<div class="txt" style="position:absolute; left:37px; top:507px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">the small intestine by a speciﬁc transporter, which was encoded</span></div>
<div class="txt" style="position:absolute; left:37px; top:517px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">by the </span><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Slc12a8 </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">gene as demonstrated in </span><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">in vitro </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and </span><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">in vivo </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">studies.</span></div>
<div class="txt" style="position:absolute; left:37px; top:528px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Even though a large number of preclinical studies have provided a</span></div>
<div class="txt" style="position:absolute; left:37px; top:538px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">highly promising possibility for developing NMN as an evidence-</span></div>
<div class="txt" style="position:absolute; left:37px; top:549px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">based anti-aging health product, its safety and effectiveness on</span></div>
<div class="txt" style="position:absolute; left:37px; top:559px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">human physiology remains unclear. The toxicological and clinical</span></div>
<div class="txt" style="position:absolute; left:37px; top:570px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">evidence to back up its utility is currently scarce. Despite this,</span></div>
<div class="txt" style="position:absolute; left:37px; top:580px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN supplements are already available in the market and consid-</span></div>
<div class="txt" style="position:absolute; left:37px; top:590px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">erably used by consumers as anti-aging health products. Therefore,</span></div>
<div class="txt" style="position:absolute; left:37px; top:601px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">in addition to animal models, human trails to investigate the safety</span></div>
<div class="txt" style="position:absolute; left:37px; top:611px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and efﬁcacy of NMN should be conducted focusing on toxicological</span></div>
<div class="txt" style="position:absolute; left:37px; top:622px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">parameters and safe metabolite levels in the human body [8].</span></div>
<div class="txt" style="position:absolute; left:49px; top:631px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Increased attention on potential pro-longevity effects of NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+</span></div>
<div class="txt" style="position:absolute; left:37px; top:643px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">precursors over the recent years has led to increased consumption</span></div>
<div class="txt" style="position:absolute; left:37px; top:653px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">of nicotinamide either as a clinical treatment or a dietary supple-</span></div>
<div class="txt" style="position:absolute; left:37px; top:664px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ment, raising concerns on the safety of their long-term usage.</span></div>
<div class="txt" style="position:absolute; left:37px; top:674px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Nicotinamide has been found to cause adverse effects on several</span></div>
<div class="txt" style="position:absolute; left:37px; top:684px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">organs in the human body such as kidney, liver, pancreatic </span><span class="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">b</span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">-</span></div>
<div class="txt" style="position:absolute; left:37px; top:695px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">cells and cells in plasma and induce nausea, stomach discomfort</span></div>
<div class="txt" style="position:absolute; left:37px; top:706px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and headaches [63,64]. In addition, high dose of nicotinamide sup-</span></div>
<div class="txt" style="position:absolute; left:37px; top:716px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">plementation is associated with decreased insulin sensitivity and</span></div>
<div class="txt" style="position:absolute; left:37px; top:726px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">increased oxidative stress [64]. However, NMN supplementation</span></div>
<div class="txt" style="position:absolute; left:37px; top:737px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">has been found to have signiﬁcant recovering effects on hepatocyte</span></div>
<div class="txt" style="position:absolute; left:37px; top:747px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">functions and liver pathologies in early-stage of ethanol toxicity,</span></div>
<div class="txt" style="position:absolute; left:306px; top:67px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">instead of causing adverse effects to the liver [65]. It has also been</span></div>
<div class="txt" style="position:absolute; left:306px; top:78px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">found to improve insulin sensitivity and oxidative stress in animal</span></div>
<div class="txt" style="position:absolute; left:306px; top:88px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">models [23,29].</span></div>
<div class="txt" style="position:absolute; left:318px; top:99px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Although, nicotinamide supplementation induced DNA damage</span></div>
<div class="txt" style="position:absolute; left:306px; top:109px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and oxidative DNA damages in various tissues of the body such as</span></div>
<div class="txt" style="position:absolute; left:306px; top:120px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">renal and hepatic tissues [66], NMN has been proven to reduce</span></div>
<div class="txt" style="position:absolute; left:306px; top:130px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">DNA damage and accumulation of ROS [32,42]. Supplementation</span></div>
<div class="txt" style="position:absolute; left:306px; top:141px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">of nicotinamide caused neurodegeneration of dopaminergic neu-</span></div>
<div class="txt" style="position:absolute; left:306px; top:151px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">rons and structural brain changes and behavioural deﬁcits in rats</span></div>
<div class="txt" style="position:absolute; left:306px; top:162px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,127,173,1);">[67]. Supplementation of NMN has been demonstrated to stimu-</span></div>
<div class="txt" style="position:absolute; left:306px; top:172px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">late neuroprotective effects and ameliorate cognitive decline and</span></div>
<div class="txt" style="position:absolute; left:306px; top:182px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">behavioural dysfunctions [35,36]. Rolfe [68] reported that adminis-</span></div>
<div class="txt" style="position:absolute; left:306px; top:193px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">tration of nicotinamide and niacin may cause development of PD,</span></div>
<div class="txt" style="position:absolute; left:306px; top:203px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">whereas supplementation of NMN has been found to be a promis-</span></div>
<div class="txt" style="position:absolute; left:306px; top:214px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ing therapeutic remedy for PD [51].</span></div>
<div class="txt" style="position:absolute; left:318px; top:223px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NR is also a precursor of NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and administration of NR has the</span></div>
<div class="txt" style="position:absolute; left:306px; top:233px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">capability to elevate body NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">levels. According to the results of</span></div>
<div class="txt" style="position:absolute; left:306px; top:245px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">clinical trials that have been performed to assess the safety of NR</span></div>
<div class="txt" style="position:absolute; left:306px; top:256px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">administration, NR supplementation increased LDL cholesterol</span></div>
<div class="txt" style="position:absolute; left:306px; top:266px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">levels in the body [69] and enhanced fatty liver conditions [70]</span></div>
<div class="txt" style="position:absolute; left:306px; top:277px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">as adverse effects. Nevertheless, NMN administration was</span></div>
<div class="txt" style="position:absolute; left:306px; top:287px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">observed to improve plasma lipid proﬁle, ameliorating free fatty</span></div>
<div class="txt" style="position:absolute; left:306px; top:298px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">acids, triglycerides and cholesterol levels and lower intrahepatic</span></div>
<div class="txt" style="position:absolute; left:306px; top:308px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">triglyceride levels in mice [10]. Shi et al. [71] have shown that</span></div>
<div class="txt" style="position:absolute; left:306px; top:318px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">excessive dose of NR generated white adipose tissue dysfunction</span></div>
<div class="txt" style="position:absolute; left:306px; top:329px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and heightened insulin resistance in mice. However, contradictory</span></div>
<div class="txt" style="position:absolute; left:306px; top:339px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">results have been reported with NMN supplementation as it</span></div>
<div class="txt" style="position:absolute; left:306px; top:350px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">reduced adiposity and enhanced insulin sensitivity [24,72].</span></div>
<div class="txt" style="position:absolute; left:318px; top:359px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN as another precursor of NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+</span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">, has the potential to encoun-</span></div>
<div class="txt" style="position:absolute; left:306px; top:369px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ter similar safety concerns and challenges as other NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">precur-</span></div>
<div class="txt" style="position:absolute; left:306px; top:381px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">sors. Thus, further clinical studies on the safety and toxicology of</span></div>
<div class="txt" style="position:absolute; left:306px; top:392px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN are urgently needed. Mehmel et al. [60] argued that NR is a</span></div>
<div class="txt" style="position:absolute; left:306px; top:401px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">more suitable NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">precursor as an anti-aging treatment. This</span></div>
<div class="txt" style="position:absolute; left:306px; top:413px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">highlights the needs to study adverse effects of nicotinamide and</span></div>
<div class="txt" style="position:absolute; left:306px; top:423px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN, even though NMN appears to have considerable beneﬁcial</span></div>
<div class="txt" style="position:absolute; left:306px; top:434px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">pharmacological actions in preclinical studies. Yoshino et al. [57]</span></div>
<div class="txt" style="position:absolute; left:306px; top:444px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">conducted a clinical trial, supplementing 250 mg/day of NMN for</span></div>
<div class="txt" style="position:absolute; left:306px; top:454px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">10 weeks to 25 prediabetes women who were overweight or obese</span></div>
<div class="txt" style="position:absolute; left:306px; top:465px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">in order to identify effect on body composition, gene expression</span></div>
<div class="txt" style="position:absolute; left:306px; top:475px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">proﬁle, insulin signalling and insulin sensitivity and observed</span></div>
<div class="txt" style="position:absolute; left:306px; top:486px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">potential metabolic beneﬁts without any adverse effects.</span></div>
<div class="txt" style="position:absolute; left:318px; top:496px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">A toxicological study for NR chloride has been done in a clinical</span></div>
<div class="txt" style="position:absolute; left:306px; top:507px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">setting, and the no observed adverse effect level (NOAEL) was</span></div>
<div class="txt" style="position:absolute; left:306px; top:517px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">300 mg/kg/day and the lowest observed adverse effect level was</span></div>
<div class="txt" style="position:absolute; left:306px; top:528px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">1000 mg/kg/day [73]. No such data is available for human admin-</span></div>
<div class="txt" style="position:absolute; left:306px; top:538px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">istration of NMN yet. However, Cros et al. [74] investigated sub-</span></div>
<div class="txt" style="position:absolute; left:306px; top:549px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">chronic oral toxicity, acute oral toxicity, genotoxicity and</span></div>
<div class="txt" style="position:absolute; left:306px; top:557px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">mutagenicity of high purity synthetic form of NMN (NMN-C</span><span class="f5" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">Ò</span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:306px; top:570px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">using female Sprague-Dawley rats (7 weeks old). According to</span></div>
<div class="txt" style="position:absolute; left:306px; top:578px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">the results, NOAEL of NMN-C</span><span class="f5" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">Ò </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">was </span><span class="f3" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">!</span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">1500 mg/kg/d. At an oral</span></div>
<div class="txt" style="position:absolute; left:306px; top:589px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">administration dose of 2666 mg/kg of NMN-C</span><span class="f5" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">Ò</span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">, no treatment-</span></div>
<div class="txt" style="position:absolute; left:306px; top:601px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">associated adverse effects or mortality were nor resulted.</span></div>
<div class="txt" style="position:absolute; left:306px; top:610px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN-C</span><span class="f5" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">Ò </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">did not show toxic effects and appeared to be safe over</span></div>
<div class="txt" style="position:absolute; left:306px; top:622px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">a 90-day sub-chronic period of repeated oral administration at</span></div>
<div class="txt" style="position:absolute; left:306px; top:632px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">doses of 375, 750 and 1500 mg/kg/d.</span></div>
<div class="txt" style="position:absolute; left:318px; top:643px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Conze, Crespo-Barreto, and Kruger [75] determined safety of a</span></div>
<div class="txt" style="position:absolute; left:306px; top:652px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">synthetic form of NR namely, Niagen</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">TM </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">using </span><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">in vitro </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and rat toxi-</span></div>
<div class="txt" style="position:absolute; left:306px; top:664px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">cological study, and found that it was not genotoxic. The lowest</span></div>
<div class="txt" style="position:absolute; left:306px; top:673px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">observed adverse effect level for Niagen</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">TM </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">was 1000 mg/kg body</span></div>
<div class="txt" style="position:absolute; left:306px; top:685px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">weight/day and NOAEL was 300 mg/kg body weight/day. Further-</span></div>
<div class="txt" style="position:absolute; left:306px; top:695px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">more, NR has been examined in six clinical trials, where it has been</span></div>
<div class="txt" style="position:absolute; left:306px; top:706px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">established that it is safe for short-term (8 days) and long-term</span></div>
<div class="txt" style="position:absolute; left:306px; top:716px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(6 weeks) supplementation in compliance with conﬁrmed oral</span></div>
<div class="txt" style="position:absolute; left:306px; top:726px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">availability [60]. These values have not been established regarding</span></div>
<div class="txt" style="position:absolute; left:306px; top:737px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN supplementation. Furthermore, recently, NR has been</span></div>
<div class="txt" style="position:absolute; left:306px; top:747px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">granted Generally Recognised as Safe (GRAS) status by the US Food</span></div>
<div class="txt" style="position:absolute; left:291px; top:764px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">274</span></div>
</body>
</html>
